Vaccines 2013, 1(3), 278-292; doi:10.3390/vaccines1030278
Review

Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination

1 Laboratory of Adjuvant Innovation, National Institute of Biomedical Innovation, 7-6-8 Saito-asagi, Ibaraki, Osaka 567-0085, Japan 2 Laboratory of Vaccine Science, Immunology Frontier Research Center, Osaka University, 3-1 Yamadaoka, Suita, Osaka 567-0871, Japan 3 Laboratory of Malaria Immunology, Immunology Frontier Research Center, Osaka University, 3-1 Yamadaoka, Suita, Osaka 567-0871, Japan
* Author to whom correspondence should be addressed.
Received: 13 June 2013; in revised form: 6 July 2013 / Accepted: 9 July 2013 / Published: 18 July 2013
(This article belongs to the Special Issue DNA Vaccines)
PDF Full-text Download PDF Full-Text [685 KB, Updated Version, uploaded 23 July 2013 10:26 CEST]
The original version is still available [685 KB, uploaded 18 July 2013 11:45 CEST]
Abstract: DNA vaccines can induce both humoral and cellular immune responses. Although some DNA vaccines are already licensed for infectious diseases in animals, they are not licensed for human use because the risk and benefit of DNA vaccines is still controversial. Indeed, in humans, the immunogenicity of DNA vaccines is lower than that of other traditional vaccines. To develop the use of DNA vaccines in the clinic, various approaches are in progress to enhance or improve the immunogenicity of DNA vaccines. Recent studies have shown that immunogenicity of DNA vaccines are regulated by innate immune responses via plasmid DNA recognition through the STING-TBK1 signaling cascade. Similarly, molecules that act as dsDNA sensors that activate innate immune responses through STING-TBK1 have been identified and used as genetic adjuvants to enhance DNA vaccine immunogenicity in mouse models. However, the mechanisms that induce innate immune responses by DNA vaccines are still unclear. In this review, we will discuss innate immune signaling upon DNA vaccination and genetic adjuvants of innate immune signaling molecules.
Keywords: DNA vaccine; innate immune responses; adjuvant; DNA sensor

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Kobiyama, K.; Jounai, N.; Aoshi, T.; Tozuka, M.; Takeshita, F.; Coban, C.; Ishii, K.J. Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination. Vaccines 2013, 1, 278-292.

AMA Style

Kobiyama K, Jounai N, Aoshi T, Tozuka M, Takeshita F, Coban C, Ishii KJ. Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination. Vaccines. 2013; 1(3):278-292.

Chicago/Turabian Style

Kobiyama, Kouji; Jounai, Nao; Aoshi, Taiki; Tozuka, Miyuki; Takeshita, Fumihiko; Coban, Cevayir; Ishii, Ken J. 2013. "Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination." Vaccines 1, no. 3: 278-292.

Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert